FluGen, Inc.
PrivateLast Round
Grant
Jul 1, 2021
Total Funding Raised
$41.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FluGen, Inc. operates in Healthcare & Life Sciences and is based in Madison, Wisconsin. Its latest recorded funding round was a Grant round in July 2021.
FluGen, Inc. is a biotechnology company developing vaccines for influenza and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FluGen, Inc. Comparables
Compare FluGen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivaldi Biosciences, Inc. | 93% | |
| Osivax | 87% | |
| Blue Lake Biotechnology, Inc. | 82% |
For institutional investors. Book with your work email.
FluGen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2021 | ||||
| Grant | Oct 18, 2017 | ||||
| Series A Extension | Apr 12, 2017 | ||||
| Series A | Aug 25, 2015 | ||||
| VC Round | Feb 21, 2011 | ||||
Angel | May 8, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FluGen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| State of Wisconsin Investment Board | Series A |
| Venture Investors LLC | Series A |
| U.S. Department of War | Grant |
| Knox Equity Group LLC | Series A |
| Wisconsin Alumni Research Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 183% MoM, reaching 5.8K.
- Jan 26, 2026
Monthly visitors increased 114% MoM, reaching 3.6K.
For institutional investors. Book with your work email.
FluGen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FluGen, Inc.'s valuation, stock price, and market status.
Is FluGen, Inc. a public or private company?
FluGen, Inc. is a private company.
What is the current stock price of FluGen, Inc.?
FluGen, Inc. is a private company, so its shares have no public market price. Caplight tracks FluGen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FluGen, Inc. worth (valuation)?
Valuation information for FluGen, Inc. is not publicly available.
Can I buy FluGen, Inc. stock?
FluGen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FluGen, Inc.'s last funding round?
FluGen, Inc.'s most recent funding round was Grant on July 1, 2021.
Who are the main investors in FluGen, Inc.?
Key investors in FluGen, Inc. include Venture Investors LLC.
Will FluGen, Inc. IPO soon?
No public IPO plans have been announced for FluGen, Inc..
How can I track FluGen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in FluGen, Inc.'s shares on secondary markets.